Fig. 4
From: Prognostic, oncogenic roles, and pharmacogenomic features of AMD1 in hepatocellular carcinoma
In vitro validation experiments. (A) qRT‒PCR validation of AMD1 expression in human normal liver cells (L02) and HCC cell lines. (B-C) qRT‒PCR validation of transfection efficiency in Huh7 and HepG2 cell. (D) The effect of silencing AMD1 on cell proliferation was explored via the cell counting kit-8 assay. (E) The wound healing assay was used to assess the effect of silencing AMD1 on cell migration. (F) The colony formation assay was conducted to detect HCC cell proliferation after silencing AMD1. (G) Matrigel invasion assay was used to assess the effect of silencing AMD1 on HCC cell invasion. The error bars indicate standard deviation. **p < 0.01, and ***p < 0.001